About Erina Pharma

Erina Pharma Drug, Cosmetic, Medical Device, R&D, Consulting Ltd Co, founded by Assoc. Prof. Dr. Nazlı Erdoğdu has been operated in Hacettepe Technopolis 6th R&D Building Block C.

The company provides consultancy in areas such as formulation development for pharmaceuticals, medical devices and cosmetics as well as preparation of registration dossiers for medicinal products for human use and biocidal products, preclinical and clinical studies. It also provides consultancy on application to national and international funding organizations for pharmaceuticals, medical devices and cosmetics, project writing and project presentation. It also provides services on product information dossier preparation and formulation development for cosmetic products.

Assoc. Prof. Dr. Nazlı Erdoğdu

Assoc. Prof. Dr. Nazlı Erdoğdu graduated from Hacettepe University Faculty of Pharmacy in 2008. She received her Master of Science Degree and PhD degree in 2015 from Hacettepe University Pharmaceutical Technology Programme. During her doctoral thesis, she worked in Aalborg University, Department of Chemistry, Biotechnology, and Environmental Engineering and was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 2214-A International Research Fellowship Programme.

After receiving her PhD degree, she received the title of Assistant Professor in 2018 and Associate Professor in 2022 at Hacettepe University Faculty of Pharmacy. Erdoğdu is currently working as an Associate Professor in the Department of Pharmaceutical Technology. Dr. Erdoğdu is also a member of the Department of Cosmetology, Faculty of Pharmacy, Hacettepe University. Her scientific studies have been published in peer-reviewed international journals and book chapters. She has 20 scientific articles published in Web of Science and Scopus journals and 6 book chapters in A, B and C categories in Sense Ranking. Her h-index is 10.

Her research areas are preparation and characterization of nanotechnology based drug delivery systems, cancer treatment, targeting strategies, oral bioavailability, skin drug delivery, topical and transdermal drug delivery systems. She specializes in formulation development, preclinical and clinical evaluation, and cosmetic product development.